Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

NCT00480610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: tacrolimus ointment
DRUG: Placebo ointment

Sponsor

Astellas Pharma Inc